Clinical Pathway STEMI | PDF - Scribd This document outlines the clinical pathway for treating ST elevation myocardial infarction (STEMI) patients at RSU Dustira
Thrombolysis for STEMI Clinical Pathway | Queensland Health %PDF-1 6 %âãÏÓ 864 0 obj > endobj 898 0 obj > Filter FlateDecode ID[98C8B42CAC444423976DF5FD4618461F>13F8092A2219E848B0E931FAF0F2DCF9>] Index[864 64] Info 863 0 R Length 145 Prev 246240 Root 865 0 R Size 928 Type XRef W[1 3 1]>>stream hÞbbd` ``b``v‘Œ[A$“*ˆd« ³ËÁ¤ ˜¼ À¤ XÍ10 ŒX߃H 0™ ï‚Év°ùG@¤W Xñ °^Q É "Ë
Systems of Care for ST-Segment–Elevation Myocardial Infarction for patients with ST-segment–elevation myocardial infarction (STEMI) In the years since, morbidity and mortality rates have declined, and research has led to significant developments that have broadened our concept of the STEMI system of care
STEMI Clinical Pathway | PDF | Percutaneous Coronary Intervention . . . STEMI Clinical Pathway - Free download as PDF File ( pdf), Text File ( txt) or read online for free This document appears to be a clinical pathway for treating patients experiencing ST elevation myocardial infarction (STEMI)
Chest Pain Acute Coronary Syndromes (ACS) Clinical Pathway Clinical Pathway Notes 1 Omit nitrates if history of recent PDE use; use NTG with caution if RV ischemia is suspected 2 Morphine and other IV opioids may reduce absorption and or efficacy of oral antiplatelet therapy 3 Ticagrelor exclusions include h o major bleed or bleeding diathesis, prior CVA TIA, known hepatic insufficiency,
CLINICAL PRACTICE GUIDELINES Management of ST Elevation . . . - NHAM Previous CPG STEMI (2014) Current CPG STEMI (2019) Distinguishing the difference between myocardial injury and Myocardial Infarction (MI) - Recognition that all myocardial injury is not necessarily due to MI No clear differentiation between myocardial injury and MI